Abstract--Inhibition of free radical mechanisms by desferrioxamine, an iron chelator, is often thought to be a good indicator of iron-catalyzed hydroxyl radical (OH') production. The specificity of desferrioxamine is critical for such identification. This study was undertaken to determine whether desferrioxamine could prevent the in vitro cytotoxic reactions of hypochlorous acid (HOC1), a major neutrophil-derived oxidant. Red blood cells were used as a target for HOCI, and cell lysis and haemoglobin oxidation were measured. Desferrioxamine, and its ironchelated form, ferrioxamine, were shown to prevent both effects of HOC1. However, desferrioxamine was 6 to 8 times more efficient than either ferrioxamine or taurine, another amine which prevents HOCl-mediated cell lysis, in preventing both lysis and Hb oxidation. After reaction with HOCI, ferrioxamine and taurine retained almost all the oxidizing equivalents as long-lived chloramine. However, with desferrioxamine less than half the oxidizing equivalents were recovered as chloramines indicating that sites other than the terminal amine reacted with HOC1. The chloramines formed were able to oxidize molecules in solution, but being hydrophilic they were confined to the extracellular medium and cell lysis did not occur. The results indicate that scavenging of HOCI could be a factor in the inhibition by desferrioxamine of neutrophil-mediated cell lysis in vitro.
INTRODUCTION
Phagocytic cells, particularly polymorphonuclear leukocytes (neutrophils), produce high concentrations of activated forms of oxygen when stimulated.~'2 These oxidants play a major role in the pathogenesis of acute inflammation, contribute to tissue injury in the lung, joint, and kidney, and may be involved in ischemia reperfusion injury. 3 6 Although evidence for the role of neutrophil-derived oxidants in mediating tissue injury is convincing, 3-6 identification of the oxidant species responsible has proven elusive. Determination of the responsible oxidant is dependent on the use of inhibitors. However, the lack of specificity of many inhibitors or scavengers complicates the identification of the oxidants, particularly the hydroxyl radical (OH'), which is extremely reactive. Desferrioxamine, an iron chelator which rePresent address and address for correspondence: Department of Pathology, Christchurch School of Medicine, Christchurch Hospital, Christchurch, New Zealand. 331 moves the iron catalyst required for OH" production, has been widely used to implicate the involvement of OH" in neutrophil-mediated events. Inhibition by desferrioxamine, coupled with an inability of the ironsaturated form, ferrioxamine, to prevent oxidant-mediated injury, has been taken as evidence of iron-mediated OH" reactions. 7 10 Desferrioxamine and ferrioxamine, however, are amines ( Fig. 1) , and would be expected to react with hypochlorous acid (HOC1), which is produced by neutrophils and monocytes. Myeloperoxidase, an azurophil granule enzyme, catalyzes the reaction:
HOCI is a potent oxidant which reacts readily with a wide range of biological molecules. ~-~4 On reaction with amines, chioramine derivatives containing the N--C1 bond are formed J5-~7
HOCI + RNH2
) RNHCI + H20
A. Although chloramines retain the oxidizing equivalents of HOC1, the experiments of Thomas et al. [16] [17] [18] [19] have clearly demonstrated that their toxicity towards cellular targets is dependent on their ability to penetrate cell membranes. Lipophilic chloramines such as monochloramine retain or enhance the toxicity of HOC1, whereas hydrophilic chloramines do not penetrate the cell membrane and, therefore, limit the toxicity towards cellular targets. 16, 19 The aim of this study was to determine whether reaction of HOC1 with desferrioxamine or ferrioxamine could prevent HOCl-mediated cellular injury. As a model, we have used red blood cells, monitoring cell lysis as a membrane event, and haemoglobin oxidation. The ability of desferrioxamine and ferrioxamine to prevent these reactions was compared with taurine, an amine compound known to inhibit HOCl-mediated red blood cell lysis.19. 20 We also investigated whether reaction with HOC1 affects the subsequent ability of desferrioxamine to form iron complexes.
MATERIALS AND METHODS

Materials
NaOC1, from Fisher Chemical Co. was diluted in phosphate buffer, pH 7.4. The concentration of HOC1/ OC1 was determined after reaction with monochlorodimedon, with the decrease in A290 being used to calculate the loss of monochlorodimedon. The extinction coefficient used was 1.99 × 10 4 M-I. 21 Desferrioxamine was obtained from CIBA Laboratories, Horsham, England as desferrioxamine mesylate (desferal). Ferrioxamine was prepared by the addition of a molar equivalent of FeC13 to desferrioxamine in solution. 5-Thio-2-nitrobenzoic acid (TNB) was formed from 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB), either by reduction with NaBH4 followed by incubation at 37°C overnight to remove any remaining reducing agents, 22 or by exposing DTNB to 0.1 M NaOH for 2 rain, then readjusting the pH to 7.4 with HC1. 23 Unless stated otherwise, all reagents were from Sigma Chemical Co., St. Louis, MO, USA.
Lysis of red blood cells and haemoglobin oxidation
Red cells were prepared from freshly drawn peripheral blood of normal donors. After washing 5 times with 0.01 M sodium phosphate, pH 7.4, containing 138 mM NaCI and 2.7 mM KC1 (PBS) to remove plasma and white cells, a suspension of 0.25% (v/v) was prepared in PBS. To the red cell suspension (0.9 mL) in a cuvette, HOC1/OC1-(0.1 mL) was added with rapid mixing. The rate of red cell lysis was determined by continuously monitoring the turbidity of the suspension at 700 nm. When desferrioxamine, ferrioxamine, or taurine was present, these were added to the red cell suspension prior to addition of HOCI.
After reaction with HOC1, the sample was centrifuged at 400 × g for 5 min. The red cell pellet (if any) was lysed in 1 mL 5 mM phosphate buffer, pH 7.4. This was combined with the supernatant and the extent of hemoglobin oxidation in the total sample, representing lysed and unlysed cells, was determined by reading the absorbances at 700, 630,577, and 560 nm. The concentration (mM) of oxyHb, MetHb, and hemichrome were calculated from the absorbances after correcting for turbidity by subtraction of the 700 nm reading. The levels of desferrioxamine, ferrioxamine, and taurine which gave 50% inhibition of lysis and Hb oxidation were estimated from reciprocal plots of percent inhibition versus concentration of inhibitor.
Chloramine formation
The amount of chloramine formed after reaction of HOC1 with amines was determined by the oxidation of TNB to DTNB, according to the stoichiometry:
Solutions of desferrioxamine or taurine (0.9 mL of 1.1 mM each) were reacted with HOC1 in 100/~L to give a final concentration of 0.25-3 mM. HOC1 was added slowly while stirring vigorously on a vortex mixer, and the tubes were left for 10 min at room temperature to ensure complete reaction of HOC1 with the amine compound. Aliquots of 25 /zL and 50/zL were removed and mixed with excess TNB. The decrease in absorbance at 412 nm was measured and the amount of TNB oxidized calculated using an extinction coefficient of 1.36 × 10 4 M -1 cm 118
Iron binding by desferrioxamine
The ability of desferrioxamine to chelate Fe after reaction with HOC1 was determined. Desferrioxamine (1 mM) was reacted with 0.4-4 mM HOC1 in a final volume of 1 mL, and after 10 min at room temperature, FeCI3 was added to 1 mM final concentration. The amount of ferrioxamine formed was measured from the absorbance maximum at 430 nm 9 and determined from a standard curve of ferrioxamine of known concentrations.
RESULTS
Inhibition of HOCl-mediated red cell lysis and Hb oxidation
Addition of HOC1 to red cell suspensions caused lysis of the cells, measured as a decrease in turbidity at 700 nm ( Fig. 2A) , and Hb oxidation (Fig. 2B) . Lysis was immediate on addition of HOC1 at concentrations above 0.3 mM and below this showed a lag time of 1-3 min. These results are similar to those of Grisham et al.~9 Spectral analysis showed that hemoglobin was oxidized to methemoglobin and hemichrome, a denatured ferric derivative (Fig. 2B) . In all subsequent experiments with inhibitors, we used 0.5 mM HOC1 (final concentration) with 0.9 mL of suspension of 0.25% red cells.
As shown in Fig. 3 , desferrioxamine was more efficient than ferrioxamine or taurine at preventing HOCl-mediated cell lysis. Concentrations at which 50% inhibition was observed were 7-8 times lower than those of either ferrioxamine or taurine (Table 1) . in turn, ferrioxamine was approximately 1.5 times more efficient than taurine at preventing red cell lysis (p < 0.001) (Fig. 3 and Table 1 ). Desferrioxamine was also 6-8 times more efficient than either ferrioxamine or taurine at inhibiting Hb oxidation by HOC1 (Fig. 4 and Table 1 ).
Chloramine formation
The yields of long-lived chloramines produced by reaction of desferrioxamine, ferrioxamine, and taurine with HOC1 were determined by reaction with TNB. With taurine virtually all the oxidizing equivalents were recovered as a chloramine, as has been shown previously by others. 25 Approx. 90% of the oxidizing equivalents added to ferrioxamine were recovered (Fig.  5) . In contrast, reaction of desferrioxamine with HOC1 resulted in a lower recovery of chloramine (Fig. 5) . At a ratio of HOC1 to desferrioxamine of 0.25 : 1 the yield of chloramine was approximately 70%, but it decreased to less than 30% when the ratio was 3: 1. These results suggest that HOC1 can react with the "~' 0.5 E.. 
Inhibitor] mM
Inhibitor] mM desferrioxamine molecule at sites other than the terminal amine group. Whether the chloramines could lyze red cells and oxidize Hb was investigated. Desferrioxamine, ferrioxamine, and taurine (1 mM each) were reacted with 1 mM HOCI for 10 min and the formation of chloramines was tested by reaction with TNB. Each chloramine was incubated with a 0.25% suspension of red cells for 1 h at room temperature and the extent of lysis and Hb oxidation determined. A small amount of Hb oxidation was seen with desferrioxamine and ferrioxamine, and none with taurine (Table 2) . No cell lysis was observed in any of the samples. In contrast, when the chloramines were incubated with a fresh hemolysate, there was rapid oxidation of Hb (Table 2 ). These results demonstrate that the chloramine derivatives of desferrioxamine and ferrioxamine cannot gain access to intracellular molecules and confine their oxidizing capacity to the extracellular medium.
Effect of HOCI on iron chelation by desferrioxamine
The ability of desferrioxamine to complex iron after reaction with HOC1 was determined. Figure 6 shows that the addition of a two-fold excess of HOCI decreased the ability of desferrioxamine to bind iron by 50%, and a four-fold excess almost completely inhibited iron binding. Reaction with HOC1 did not alter the absorbance of desferrioxamine at 430 nm. HOC1 added to preformed ferrioxamine in up to a two-fold molar excess did not cause iron release, since no changes in the absorbance spectrum were observed.
DISCUSSION
Iron chelation by desferrioxamine has been widely used to determine the involvement of OH" in free rad- ical mechanisms. While its use in controlled experimental conditions may be well defined, its specificity as an inhibitor in more complex radical-generating systems is less certain. When neutrophils or monocytes are the generating source, the major oxidant measured in the extracellular medium is HOC1, formed by the reaction of myeloperoxidase with H202 .26'27 Our experiments have shown that desferrioxamine reacts readily with HOC1/OC1-and, at the concentrations often used in experimental systems, 7-m prevented red cell lysis. Hb oxidation, which under these conditions occurs extracellularly subsequent to lysis, ~9 was also inhibited. Ferrioxamine also reacted with HOC1, but was a much less efficient inhibitor than desferrioxamine.
Our results have implications for the interpretation of experiments in which these compounds are used to determine the involvement of OH" in free radical reactions mediated by neutrophils. In some studies, greater inhibition of neutrophil cytotoxic reactions by desferrioxamine than ferrioxamine has been taken as an indication of the involvement of OH" generated by the iron-catalyzed Haber-Weiss reaction. 7 ~0 Our experiments showing that desferrioxamine is a more efficient scavenger of HOCI than is ferrioxamine imply that selective inhibition of neutrophil-mediated cytotoxicity by desferrioxamine could also indicate an HOCl-mediated reaction. This is particularly so when inhibition requires millimolar concentrations of desferrioxamine. Our results are in agreement with a recent report which showed that desferrioxamine prevents iodination reactions by myeloperoxidase and eosinophil peroxidase. 28 The specificity of desferrioxamine has also been questioned in other studies showing that it can react with O2 ~-to form a nitroxide radical. 29 HOC1 reacts readily with amines to produce chloramines. These retain the oxidizing equivalents of HOC1, but their biological reactivity can be modified by their hydrophobicity and consequent ability to penetrate cell membranes. Hence, lipophilic chloramines Inhibition of acid-mediated reactions by desferrioxamine 335 mM HOCI added cause cell lysis similarly to HOC1 whereas hydrophilic chloramines are largely confined to the extracellular medium and are much less toxic to cellular targets. ~6-m We showed that desferrioxamine and ferrioxamine, like taurine, formed chloramine derivatives. Extended incubation of red cells with the chloramines did not result in cell lysis or significant Hb oxidation. In contrast, Hb in hemolysate was readily oxidized. Both desferrioxamine and ferrioxamine are hydrophilic molecules, 3° hence their chloramine derivatives, like taurine chloramine, should not penetrate the cell membrane and this would explain why lysis was prevented. In a recent study, Wasil et al. 3j showed that desferrioxamine did not protect oh-antitrypsin from HOC1-dependent inactivation. While they inferred from this that desferrioxamine did not react with HOC1, it is likely that oxidation of cq-antitrypsin occurred by reaction with the desferrioxamine chloramine derivative. Hence, their results do not exclude a reaction between desferrioxamine and HOCI. Indeed, inhibition of HOCl-mediated events by desferrioxamine will be more effective when cellular targets are used. On reaction of ferrioxamine with HOC1, we found that almost all the oxidizing equivalents were recovered as chloramine, indicating that the terminal -NH2 group was the primary reaction site. With desferrioxamine, less than half the oxidizing equivalents were recovered as chloramine, suggesting that sites other than the terminal -NH2 competed successfully for the HOCI. This could involve the iron-binding sites, since reaction with HOCI prevented subsequent iron chelation. From its known chemistry 32 HOC1 reacts most readily with alkenes, and it is therefore likely that chlorination of the enol tautomers (marked with a star in Fig. 1) --N--C--CH2.
" --N--C=CH
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HO O HO OH would destroy the iron-binding site. This reaction would explain the greater efficiency of desferrioxamine as a scavenger of HOC1, since the iron-binding hydroxamic acid is not available for reaction in ferrioxamine (Fig. 1) . The differences found in the abilities of desferrioxamine and ferrioxamine to prevent neutrophil-mediated oxidative events could be further accentuated: The chloramines formed are able to oxidize extracellular components, and since desferrioxamine forms less chloramine than does ferrioxamine, it will also be considerably less toxic.
The ability of HOC1 to destroy the iron-binding capacity of desferrioxamine is also of interest with regard to the microbicidal function of neutrophils. Hydroxamic acid-type iron chelators are released by bacteria wLh 33 to scavenge iron required for bacterial gro t . HOC1-mediated destruction of the iron-binding sites of these molecules could severely restrict bacterial replication and this may be an additional microbicidal mechanism for the myeloperoxidase-HzO2-chloride system.
